Cardiology Specialties: Training Pathways, Roles & When to Refer
Cardiology has evolved into a federation of subspecialties, each addressing distinct cardiovascular disease mechanisms and patient populations. Understanding these roles ensures appropriate referral and coordinated care.
Core Training Pathway (US)
- Bachelor's degree (4 yr)
- Medical School — MD/DO (4 yr)
- Internal Medicine Residency (3 yr)
- General Cardiology Fellowship (3 yr) → Board Eligible/Certified in Cardiovascular Disease (ABIM)
- Optional Subspecialty Fellowship (1–3 yr): Additional board certification.
Total: 14–17 years post-high school.
General Cardiologist
Broad practice: prevention, risk assessment, hypertension, lipid management, stable CAD, heart failure (mild-moderate), valvular disease (stable), arrhythmia (basic), pre-op clearance. Performs/Interprets: ECG, echo, stress testing (exercise, pharmacologic), Holter/event monitor, cardiac CT (CAC), basic cardiac MRI. Manages 80–90% of CV conditions. Refers to subspecialists for advanced/interventional needs.
Subspecialties: Focus, Procedures & Referral Triggers
| Subspecialty | Focus | Key Procedures / Skills | When to Refer |
|---|---|---|---|
| Interventional Cardiology | Catheter-based structural & coronary interventions | Coronary angiography, PCI/stent, CTO, IVUS/OCT, FFR/iFR, TAVR, MitraClip, PFO/ASD closure, valvuloplasty, peripheral/renal/carotid intervention | Acute coronary syndrome, high-risk stable CAD, structural heart disease amenable to transcatheter therapy |
| Electrophysiology (EP) | Arrhythmia diagnosis & ablation | EP study, RF/cryo ablation (AF, flutter, SVT, VT), ICD/CRT-D/CRT-P implant, lead extraction, LAA occlusion (Watchman), subcutaneous ICD | Symptomatic arrhythmias, ablation candidates, device implantation/management, syncope with suspected arrhythmia |
| Heart Failure / Transplant | Advanced HF, mechanical support, transplant | GDMT optimization, CardioMEMS, LVAD (HeartMate 3), transplant evaluation/management, endomyocardial biopsy, amyloidosis/tachycardia workup | NYHA III-IV, recurrent hospitalization, EF ≤35%, device therapy candidates, transplant evaluation |
| Cardiac Imaging | Advanced multimodal imaging | Advanced echo (3D, strain, contrast), CMR (LGE, T1/T2 mapping, ECV), cardiac CT (CAC, CTA, FFR-CT), nuclear (MPI, PET viability/sarcoid), stress echo | Complex diagnostic dilemmas, pre-procedural planning, cardiomyopathies, congenital, amyloidosis, device planning |
| Pediatric Cardiology | Congenital & acquired heart disease in children | Fetal echo, catheter intervention (PDA, ASD, VSD, valve dilation), CHD surgery follow-up, cardiomyopathy, arrhythmia, transition to ACHD | Any cardiac concern in fetus/infant/child/adolescent; adult congenital heart disease (ACHD) |
| Adult Congenital Heart Disease (ACHD) | Lifelong care for congenital heart disease survivors | Complex anatomy management, pregnancy counseling, non-cardiac surgery risk, transition from pediatric | All adults with CHD (simple or complex); pregnancy in CHD |
| Preventive Cardiology | Risk reduction, lipidology, early detection | Advanced lipid testing (Lp(a), ApoB, NMR), CAC scoring, genetic counseling (FH), intensive lifestyle, novel lipids (PCSK9i, bempedoic, icosapent ethyl) | Strong family history, FH, statin intolerance, high Lp(a), early-onset CVD, risk refinement |
| Structural Heart (often overlaps Interventional) | Valvular & structural interventions | TAVR, TMVR, MitraClip, Tricuspid (TriClip, Evoque), PFO/ASD, VSD, paravalvular leak closure, BASILICA | Severe valvular disease (esp. high surgical risk), structural interventions |
| Cardio-Oncology | CV toxicity of cancer therapy | Baseline/serial echo (GLS), biomarker monitoring (troponin, BNP), anthracycline/trastuzumab/VEGF/Ibrutinib/BCR-ABL toxicity management, survivorship | Pre-chemo baseline, during/after cardiotoxic therapy, cancer survivors |
Practice Settings & Career Metrics
- Settings: Academic medical centers (teaching, research, tertiary/quaternary), private practice (single/multi-specialty), hospital-employed, VA/military, telecardiology networks.
- Job Outlook: Strong — aging population, CVD burden, subspecialty demand. Rural/underserved areas = high need + loan forgiveness.
- Compensation (Medscape 2023): Mean $408,000; Interventional $500–600k+, EP $450–550k, HF/Imaging $400–500k, General $350–450k. Academic < private.
- Challenges: Long hours (interventional/EP call), emotional intensity (end-of-life, complications), administrative burden, maintenance of certification (MOC), rapid technology evolution.
How Cardiologists Collaborate
- Heart Team: Interventional + Imaging + Surgery + HF + Anesthesia for structural decisions (TAVR, MitraClip, complex CAD).
- Multidisciplinary Clinics: Cardio-obstetrics, cardio-oncology, amyloidosis, pulmonary hypertension, aortopathy, genetic cardiomyopathy.
- Primary Care Partnership: Risk factor management, stable chronic disease, pre/post-procedure care.
For Patients: Start with general cardiologist (or PCP referral). They coordinate subspecialty referrals. For second opinions, seek academic centers with relevant Heart Teams. Board certification (ABIM) + subspecialty certification = verified training.
Open Heart Surgery - Related Articles
- The Heart's Unique Adaptations: How It Powers Life
- Chordae Tendineae: Preventing AV Valve Prolapse
- Emergency Umbilical Cord Care: First Aid Step-by-Step Guide
- Endoscopy: Procedure Types, Benefits, Preparation, and Risks
- Understanding the P Wave: What It Reveals About Atrial Activity on an ECG
- Mitral and Tricuspid Valve Closure During Ventricular Systole
- Aortic Valve Replacement: Procedures, Causes & Treatment Options
